18 / 60
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 1, January/February 2021
16
AFRICA
31. Allard-Ratick MP, Sandesara P, AA Quyyumi,
et al
. Everything in
moderation: investigating the U-shaped link between HDL cholesterol
and adverse outcomes.
US Cardiol Rev
2019;
13
(1): 49–53.
32. Reina SA, Llabre MM, Allison MA,
et al
. HDL cholesterol and stroke
risk: the multi-ethnic study of atherosclerosis.
Atherosclerosis
2015;
243
:
314–319.
33. Krishnan V, Nestler EJ. The molecular neurobiology of depression.
Nature
2008;
455
: 894–902.
34. Kinoshita K. Traumatic brain injury: pathophysiology for neurocritical
care.
J Intens Care
2016;
4
: 29.
35. Kim HG, Cheon EJ, Bai DS,
et al.
Stress and heart rate variability: a
meta-analysis and review of the literature.
Psychiatry Investig
2018;
15
(3):
235–245.
36. Flak JN, Myers B, Solomon MB,
et al
. Role of paraventricular nucleus-
projecting norepinephrine/epinephrine neurons in acute and chronic
stress.
Eur J Neurosci
2014;
39
: 1903–1911.
37. Matsuo T, Cynader MS. Localization of alpha-2 adrenergic receptors in
the human eye.
Ophthal Res
1992;
24
: 213–219.
38. Wang B, Wang Y, Wu Q,
et al
. Effects of
α
2A adrenoceptors on norepi-
nephrine secretion from the locus coeruleus during chronic stress and
depression.
J Front Neurosci
2017;
11
: 243.
39. Woldemussie E, Wijono M, Pow D. Localization of alpha-2 receptors in
ocular tissues.
Vis Neurosci
2007;
24
: 745–756.
40. Ding S. Astrocytic Ca
2+
signaling and its role in modulating cerebral blood
flow.
Ann Vasc Med Res
2014;
1
: 1006.
41. Gyoneva S, Traynelis SF. Norepinephrine modulates the motility of rest-
ing and activated microglia via different adrenergic receptors.
J Biol Chem
2013;
288
: 15291–15302.
42. Maletic V, Eramo A, Gwin K,
et al.
The role of norepinephrine and
its
α
-adrenergic receptors in the pathophysiology and treatment of
major depressive disorder and schizophrenia: a systematic review.
Front
Psychiatry
2017;
8
: 42.
43. Sánchez-Soto M, Bonifazi A, Cai NS,
et al.
Evidence for non-canonical
neurotransmitter activation: norepinephrine as a dopamine D
2
-like recep-
tor agonist.
Mol Pharmacol
2016;
89
: 457–466.
44. Qiao SN, Zhou W, Liu L-L,
et al
. Multiple cone pathways are involved in
photic regulation of retinal dopamine.
Scient Rep
2016;
6
: 28916.
45. Jäkel S, Dimou L. Glial cells and their function in the adult brain: a jour-
ney through the history of their ablation.
Front Cell Neurosci
2017;
11
: 24.
46. De Vente W, van Amsterdam JG, Olff M,
et al
. Burnout is associated with
reduced parasympathetic activity and reduced HPA axis responsiveness,
predominantly in males.
Biomed Res Int
2015;
2015
: 431725.
47. Chang YS, Ho CH, Chu CC. Risk of retinal artery occlusion in patients
with diabetes mellitus: a retrospective large-scale cohort study.
PLoS One
2018;
13
(8): e0201627.
48. Böhmer T, Manicam C, Steege A,
et al.
The alpha (1)B-adrenoceptor
subtype mediates adrenergic vasoconstriction in mouse retinal arterioles
with damaged endothelium.
Br J Pharmacol
2014;
171
: 3858–3867.
49. Wetherell MA, Craw O, Smith K. Psychobiological responses to critically
evaluated multitasking.
Neurobiol Stress
2017;
7
: 68–73.
50. Weidenfeld J, Ovadia H. The role of the amygdala in regulating the
hypothalamic-pituitary-adrenal axis in: the amygdala – where emotions
shape perception, learning and memories.
Intech Open
2017: 173–186.
51. Gallina D, Zelinka C, Fischer AJ. Glucocorticoid receptors in the
retina, Müller glia and the formation of Müller glia-derived progenitors.
Development
2014;
141
(17): 3340–3351.
52. Yu DY, Su EN, Cringle SJ,
et al
. Local modulation of retinal vein tone.
Invest Ophthalmol Vis Sci
2016;
57
(2): 412–419.
53. Liguori C, Pierantozzi M, Chiaravalloti A,
et al
. When cognitive decline
and depression coexist in the elderly: CSF biomarkers analysis can differ-
entiate Alzheimer’s disease from late-life depression.
Front Aging Neurosci
2018;
10
: 38.
54. Burrage E, Marshall KL, Santanam N,
et al.
Cerebrovascular dysfunction
with stress and depression.
Brain Circ
2018;
4
(2): 43.
55. Levis B, Benedetti A, Ioannidis JPA. Patient Health Questionnaire-9
scores do not accurately estimate depression prevalence: individual
participant data meta-analysis,
J Clin Epi
2020;
122
: 115–128.
56. Melin EA, Thulesius HO, Hillman M. Lower HDL-cholesterol, a known
marker of cardiovascular risk, was associated with depression in type 1
diabetes: a cross sectional study.
Lipids Health Dis
2019;
18
(1): 65.
57. Holven KB, Retterstøl K, Ueland T,
et al
. Subjects with low plasma HDL
cholesterol levels are characterized by an inflammatory and oxidative
phenotype.
PLoS One
2013;
8
: e78241.
58. Pikuleva IA, Curcio CA. Cholesterol in the retina: the best is yet to come.
Progress Retinal Eye Res
2014;
41
: 64–89.
59. Singh-Manoux A, Gimeno D, Kivimaki M,
et al
. Low HDL cholesterol
is a risk factor for deficit and decline in memory in midlife: the Whitehall
II study.
Arterioscl Thromb Vasc Biol
2008;
28
: 1556–1562.
60. Powers WJ, Rabinstein AA, Ackerson T,
et al
. On behalf of the American
Heart Association Stroke Council: Guidelines for the early manage-
ment of patients with acute ischemic stroke: A Guideline for healthcare
professionals from the American Heart Association/American Stroke
Association.
Stroke
2018;
158
: e46-e110.
61. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and
severity measure.
Psych Ann
2002;
32
: 1–7.
62. Dawood T, Lambert EA, Barton DA,
et al
. Specific serotonin reuptake
inhibition in major depressive disorder adversely affects novel markers of
cardiac risk.
Hypertens Res
2007;
30
(4): 285–293.